The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: DOXORUBICIN HYDROCHLORIDE.     Injury: Palmar-plantar erythrodysaesthesia syndrome     Quarter: 2016Q3

Total Records: 6     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
126141243 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome JANSSEN 57.00 YR F 0 20160823 CN
126251631 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome JANSSEN 0.00 F 0 20160805 US
126475201 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome 47.62 YR F 128 KG 20160811 US
127637491 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome JANSSEN 51.78 YR F 60 KG 20160920 IT
127763001 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome JANSSEN 0.00 0 20160923 BE
127993711 DOXORUBICIN HYDROCHLORIDE. Palmar-plantar erythrodysaesthesia syndrome JANSSEN 0.00 0 20160930 JP

Total Records: 6     Number of Pages: 1